GlassScriptPhysician profile
Kenneth Herlihy
NPI 1952304230
$552.88
in general payments reported to CMS, 2019-2025
6 companies · $77.71 in 2025
The $77.71 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.90 · 2021: $197 · 2022: $76.07 · 2023: $60.65 · 2024: $126 · 2025: $77.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $171.43 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $156.38 | 2023-2025 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $119.96 | 2021 | |
| Alcon Vision LLC | $61.07 | 2024-2025 | Rocklatan |
| Coopervision INC. | $25.39 | 2021 | |
| Oyster Point Pharma, INC. | $18.65 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Herlihy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.